A holistic approach to reducing CV risk in patients with type 2 diabetes & CVD
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality for people with diabetes and the largest contributor to the direct and indirect costs of diabetes. Approximately 65% of all CVD deaths in Australia occur in people with diabetes or prediabetes.
About the webinar
Join our webinar for a multidisciplinary discussion on the prevention of CV events in patients with both type 2 diabetes and CVD. Discussion will cover:
|
▷
|
Evidence-based strategies to reduce CV risk for patients with diabetes and CVD
|
|
▷
|
Advice on how to individualise choice of blood glucose-lowering agents
|
|
▷
|
The latest Australian blood glucose treatment algorithm for type 2 diabetes
|
|
▷
|
An update on the latest CV outcome trial data and how this impacts your practice
|
|
Leave a Reply